Document Detail

Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience.
MedLine Citation:
PMID:  11549799     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Toxic epidermal necrolysis (TEN) is a rare severe acute exfoliative drug-induced skin disorder which has recently been ascribed to alterations in the control of keratinocyte apoptosis, mediated by an interaction between the cell surface death receptor Fas and its respective ligand. A therapeutic approach with intravenous immunoglobulins (IVIG) associated with pulse methylprednisolone, based on the inhibition of Fas-mediated keratinocyte death by naturally occurring Fas-blocking antibodies included in human immunoglobulin preparations, has produced good preliminary results.
OBJECTIVE: To analyse the efficacy of IVIG in the treatment of TEN.
PATIENTS: Nine patients with erythematous body surface area ranging from 38 to 85% and dermo-epidermal detachment from 4 to 37% were treated.
RESULTS: Eight patients were healed and 1 died of septic shock and multiple organ failure. Interruption of further epidermal detachment occurred after an average of 4.8 days from the onset of IVIG therapy. Complete wound healing occurred after an average of 12 days. Concerning complications, 3 out of 8 surviving patients had acute respiratory failure requiring mechanical ventilation and 1 acute renal failure was treated with dialysis. Late sequelae were limited to dyschromia and nail dystrophies. No hypertrophic scars were observed.
CONCLUSION: IVIG therapy represents a safe and valid approach for TEN.
M Stella; P Cassano; D Bollero; A Clemente; G Giorio
Related Documents :
2754149 - Epinephrine improves expiratory flow rates in patients with asthma who do not respond t...
20930009 - Twenty-two years' experience with childhood-onset sle in a developing country: are outc...
21040139 - Peripheral nerve society guideline on the classification, diagnosis, investigation, and...
10779249 - Management of giant cell arteritis and polymyalgia rheumatica.
8641639 - Prophylaxis against infections with low-dose intravenous immunoglobulins (ivig) in chro...
11036849 - Intravenous immunoglobulin therapy for children with stevens-johnson syndrome.
15716189 - Can we obtain better specimens with an end-cutting prostatic biopsy device?
11226799 - Reduction in intraocular pressure after laser in situ keratomileusis.
23497109 - Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people wi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Dermatology (Basel, Switzerland)     Volume:  203     ISSN:  1018-8665     ISO Abbreviation:  Dermatology (Basel)     Publication Date:  2001  
Date Detail:
Created Date:  2001-09-10     Completed Date:  2001-11-01     Revised Date:  2014-07-28    
Medline Journal Info:
Nlm Unique ID:  9203244     Medline TA:  Dermatology     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  45-9     Citation Subset:  IM    
Copyright Information:
Copyright 2001 S. Karger AG, Basel
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Immunoglobulins, Intravenous / therapeutic use*
Middle Aged
Stevens-Johnson Syndrome / complications,  pathology,  therapy*
Treatment Outcome
Reg. No./Substance:
0/Immunoglobulins, Intravenous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial w...
Next Document:  The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris.